Clinical Trials Browser

Phase 1 × Mesothelioma, Malignant × Safety × Clear all

NCT04525859 2025-06-24

Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma

Phase 1 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant